The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Pilot Study of Biomarkers for Radiation Therapy
Official Title: Investigating Proteomic Biomarkers of Radiation Therapy Outcome: A Pilot Study
Study ID: NCT01050725
Brief Summary: The purpose of this study is to determine whether specific assays of DNA damage repair proteins can be used in patients undergoing radiation therapy. The ultimate goal of this research is to develop clinically useful biomarkers from blood samples that could be used to customize radiation treatment for individuals, leading to reduced side effects and improved outcomes.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Virginia Mason Medical Center, Seattle, Washington, United States
Name: Kas R Badiozamani, MD
Affiliation: Virginia Mason Hospital/Medical Center
Role: PRINCIPAL_INVESTIGATOR